TY - JOUR
T1 - Antimalarial potential and toxicity assessment of a polyherbal combination of Azadirachta indica A. Juss., Cymbopogon citratus (DC.) Stapf., and Psidium guajava L. in rodents
AU - Brou, Sygnoh Eve Pristile
AU - Kouassi, Konan Aime Brice
AU - Baidoo, Michael Frimpong
AU - Bohui, Gouegoui Serge Pacôme
AU - Agyemang, Alfred Ofori
AU - Pakora, Gilles Alex
AU - Adima, Augustin Amissa
AU - Ferrero-Gomez, Maria Lara
AU - Pereira, Dilson
AU - Azagoh-Kouadio, Richard
AU - N'guessan, Benoit Banga
AU - N'guessan, Jean David
N1 - Publisher Copyright:
Copyright © 2025 Elsevier B.V. All rights reserved.
PY - 2026/3/1
Y1 - 2026/3/1
N2 - ETHNOPHARMACOLOGICAL RELEVANCE: Malaria continues to be a major public health burden in sub-Saharan Africa, particularly due to the emergence of drug-resistant Plasmodium strains and limited access to effective therapies. In African traditional medicine, Azadirachta indica A. Juss., Cymbopogon citratus (DC.) Stapf., and Psidium guajava L. are commonly used for managing malaria. However, their combined efficacy and safety as a standardized polyherbal preparation remain underexplored. AIM OF THE STUDY: This study evaluated the antimalarial efficacy and safety profile of a polyherbal formulation (Phymepalu Extract - PPE) prepared from A. indica, C. citratus, and P. guajava in rodent models. MATERIALS AND METHODS: The antimalarial activity of the PPE extract was assessed using a 4-day curative test in Plasmodium berghei-infected mice at doses of 30, 60, 90, and 120 mg/kg body weight. Hydroxychloroquine (25 mg/kg) was used as a positive control. Acute oral toxicity was evaluated in rats according to OECD Guideline 423, while subacute (28-day) and subchronic (90-day) toxicity studies followed OECD Guidelines 407 and 408, respectively. Toxicological evaluations included clinical signs, body weight, haematological and biochemical parameters, and histopathological analysis of key organs. RESULTS: The PPE extract exhibited dose-dependent antimalarial activity, with 90 mg/kg producing the highest parasitaemia inhibition (76 %), compared to 92 % with hydroxychloroquine. No mortality or signs of acute toxicity were observed at 5000 mg/kg. Repeated administration over 28 and 90 days did not result in significant changes in clinical, haematological, biochemical, or histopathological indices, indicating good tolerability. CONCLUSION: The PPE extract demonstrated significant antimalarial activity and an excellent safety profile in preclinical models, supporting its traditional use. These findings justify further investigations toward its development as a safe and effective phytotherapeutic agent for malaria.
AB - ETHNOPHARMACOLOGICAL RELEVANCE: Malaria continues to be a major public health burden in sub-Saharan Africa, particularly due to the emergence of drug-resistant Plasmodium strains and limited access to effective therapies. In African traditional medicine, Azadirachta indica A. Juss., Cymbopogon citratus (DC.) Stapf., and Psidium guajava L. are commonly used for managing malaria. However, their combined efficacy and safety as a standardized polyherbal preparation remain underexplored. AIM OF THE STUDY: This study evaluated the antimalarial efficacy and safety profile of a polyherbal formulation (Phymepalu Extract - PPE) prepared from A. indica, C. citratus, and P. guajava in rodent models. MATERIALS AND METHODS: The antimalarial activity of the PPE extract was assessed using a 4-day curative test in Plasmodium berghei-infected mice at doses of 30, 60, 90, and 120 mg/kg body weight. Hydroxychloroquine (25 mg/kg) was used as a positive control. Acute oral toxicity was evaluated in rats according to OECD Guideline 423, while subacute (28-day) and subchronic (90-day) toxicity studies followed OECD Guidelines 407 and 408, respectively. Toxicological evaluations included clinical signs, body weight, haematological and biochemical parameters, and histopathological analysis of key organs. RESULTS: The PPE extract exhibited dose-dependent antimalarial activity, with 90 mg/kg producing the highest parasitaemia inhibition (76 %), compared to 92 % with hydroxychloroquine. No mortality or signs of acute toxicity were observed at 5000 mg/kg. Repeated administration over 28 and 90 days did not result in significant changes in clinical, haematological, biochemical, or histopathological indices, indicating good tolerability. CONCLUSION: The PPE extract demonstrated significant antimalarial activity and an excellent safety profile in preclinical models, supporting its traditional use. These findings justify further investigations toward its development as a safe and effective phytotherapeutic agent for malaria.
KW - Antimalarial activity
KW - Azadirachta indica
KW - Cymbopogon citratus
KW - Malaria
KW - Plasmodium berghei
KW - Psidium guajava
KW - Toxicity
UR - https://www.scopus.com/pages/publications/105026165388
U2 - 10.1016/j.jep.2025.120999
DO - 10.1016/j.jep.2025.120999
M3 - Article
C2 - 41352469
AN - SCOPUS:105026165388
SN - 0378-8741
VL - 358
SP - 120999
JO - Journal of Ethnopharmacology
JF - Journal of Ethnopharmacology
ER -